Hard Year Begets New Challenges

The year 2020, with its plethora of challenges from all aspects of life, may not be missed by many. The most notable challenge, the coronavirus pandemic, will carry on into 2021 (and perhaps beyond that). The resulting economic downturn has affected millions, with many facing reduced hours, layoffs, and/or challenges from remote work.

 The heated US election season is essentially over, but the political polarization that begat it remains a force in American life.

This year had the most active Atlantic basin hurricane season on record with several destructive storms making landfall. Western US forests burned in the latter half of the year, which followed massive fires in Australia.

What will 2021 bring? Perhaps just a small improvement from this past year will make it seem better by comparison, though many of the underlying challenges plaguing 2020 will almost certainly continue into 2021 and even into the rest of the 2020s.

 

Attack on Airport in Yemen Leaves Over Two Dozen Dead

 Explosions and gunfire rocked an airport in Aden, Yemen on Wednesday, killing at least 25 as members of a new Saudi-backed government arrived. One government officials, a deputy minister of public works, was killed.

The attack comes amid a county gripped in conflict, as the Iran-backed Houthis continue to hold a large swath of the nation as other separatist groups try to claim control. Saudi Arabia has been a major player in the conflict, opposing the Iran-backed Houthi group. The Yemen conflict is part of a broader power struggle in the Middle East between Sunni governments, including Saudi Arabia, and Shia Iran.

 

Vaccine Rollout Begins

The long-awaited coronavirus vaccines rolled out publicly this month, with three major ones approved by government regulators. This follows months of clinical trials and some doubt whether such vaccines would be ready by the year’s end. The rollouts  have not been without their challenges, however, as governments work to get the pandemic under control.

Pfizer’s vaccine was the first to be announced as clinically effective and safe, followed closely by Moderna’s vaccine, which uses new messenger RNA technology to create immunity. The challenges of these two vaccines, and from some others that will follow, include the need for two doses of the vaccine to be given days apart and the need for cold storage. Pfizer’s must be stored at temperatures hat are colder than Antarctica (around 70 Celsius), while Moderna’s must be kept at temperatures closer to a regular freezer (-20 Celsius).

Another vaccine, developed by researchers at the University of Oxford and AstraZeneca, does not require the cold temperatures that Pfizer’s and Moderna’s vaccines need and can instead be stored in a standard refrigerator. The United Kingdom has approved the AstraZeneca vaccine for use in the country, and this vaccine will likely be approved in other countries over time.

Vaccine immunizations are currently prioritized to healthcare workers and those at severe risk of complications, such as the elderly and immunosuppressed. Throughout 2021, as more vaccine doses are created and logistical issues sort themselves out, a greater share of the population, including healthy people with no pre-existing conditions, will begin receiving doses of the vaccine.